0001209191-19-033552.txt : 20190531
0001209191-19-033552.hdr.sgml : 20190531
20190531093315
ACCESSION NUMBER: 0001209191-19-033552
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190529
FILED AS OF DATE: 20190531
DATE AS OF CHANGE: 20190531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAIDA ANTHONY E III
CENTRAL INDEX KEY: 0001273213
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35006
FILM NUMBER: 19868828
MAIL ADDRESS:
STREET 1: 157 TECHNOLOGY DR
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000831547
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930979187
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
BUSINESS PHONE: 702-835-6300
MAIL ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
FORMER COMPANY:
FORMER CONFORMED NAME: NEOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19960819
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICUS FUNDING CORP
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-29
0
0000831547
SPECTRUM PHARMACEUTICALS INC
SPPI
0001273213
MAIDA ANTHONY E III
11500 S. EASTERN AVE.
SUITE 240
HENDERSON
NV
89052
1
0
0
0
Common Stock, $0.001 par value
2019-05-29
4
M
0
50000
6.09
A
72250
D
Common Stock, $0.001 par value
2019-05-29
4
S
0
42643
7.747
D
29607
D
Stock Option Exercise (Right to Buy)
6.09
2019-05-29
4
M
0
50000
0.00
D
2012-06-26
2019-06-26
Common Stock
50000
0
D
This transaction represents an open market sale of a portion of the expiring stock options exercised on this Form 4 to satisfy the Reporting Person's payment of the exercise price and the taxes associated with such exercise.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.695 to $7.82, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/ Kurt A. Gustafson, attorney-in-fact for Anthony E. Maida
2019-05-31